{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:04:07Z","timestamp":1791497047450,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD019787"],"award-info":[{"award-number":["DP5OD019787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1R35CA220481"],"award-info":[{"award-number":["1R35CA220481"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["400991"],"award-info":[{"award-number":["400991"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["5T32 CA177555"],"award-info":[{"award-number":["5T32 CA177555"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007100","name":"Sandler Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ccell.2018.05.014","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T10:41:36Z","timestamp":1531132896000},"page":"56-68.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation"],"prefix":"10.1016","volume":"34","author":[{"given":"Hanlin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Jorapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Hunter","family":"Shain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Botton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Donne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar N.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pincus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth S.","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwei","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris C.","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccell.2018.05.014_bib1","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-04-2970","article-title":"Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background","volume":"65","author":"Ackermann","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib2","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ccell.2018.05.014_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-pathol-012513-104658","article-title":"The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia","volume":"9","author":"Bastian","year":"2014","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.ccell.2018.05.014_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/pcmr.12422","article-title":"Genetics of melanoma progression: the rise and fall of cell senescence","volume":"29","author":"Bennett","year":"2016","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejcb.2013.10.001","article-title":"POU transcription factors in melanocytes and melanoma","volume":"93","author":"Besch","year":"2014","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.ccell.2018.05.014_bib6","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2018.05.014_bib7","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","article-title":"Easy quantitative assessment of genome editing by sequence trace decomposition","volume":"42","author":"Brinkman","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03269","article-title":"Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression","volume":"433","author":"Carreira","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.05.014_bib9","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0092-8674(91)90557-F","article-title":"The E2f transcription factor is a cellular target for the Rb protein","volume":"65","author":"Chellappan","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib11","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","article-title":"Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1755-148X.2008.00510.x","article-title":"POU domain transcription factors: BRN2 as a regulator of melanocytic growth and tumourigenesis","volume":"21","author":"Cook","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib13","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.05.014_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2014.11.014","article-title":"mTORC1 activation blocks braf(V600E)-induced growth arrest but is insufficient for melanoma formation","volume":"27","author":"Damsky","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib15","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/ng.356","article-title":"Braf(V600E) cooperates with Pten loss to induce metastatic melanoma","volume":"41","author":"Dankort","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2018.05.014_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","article-title":"Oncogenic Braf induces melanocyte senescence and melanoma in mice","volume":"15","author":"Dhomen","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ccell.2018.05.014_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.jid.5700094","article-title":"Population-based prevalence of CDKN2A mutations in Utah melanoma families","volume":"126","author":"Eliason","year":"2006","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2018.05.014_bib19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/emboj\/18.8.2106","article-title":"The p16(INK4a) tumour suppressor protein inhibits alpha(v)beta(3) integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alpha(v)beta(3) to focal contacts","volume":"18","author":"Fahraeus","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.ccell.2018.05.014_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ebiom.2017.01.013","article-title":"NFIB mediates BRN2 driven melanoma cell migration and invasion through regulation of EZH2 and MITF","volume":"16","author":"Fane","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ccell.2018.05.014_bib21","doi-asserted-by":"crossref","first-page":"8541","DOI":"10.1073\/pnas.93.16.8541","article-title":"Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population","volume":"93","author":"FitzGerald","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.05.014_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1523-1747.2002.01659.x","article-title":"Failure to detect differences in proliferation status of nevi from CDKN2A mutation carriers and non-carriers","volume":"118","author":"Florell","year":"2002","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2018.05.014_bib23","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.89.21.10557","article-title":"Homozygous deletions within human-chromosome band-9p21 in melanoma","volume":"89","author":"Fountain","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.05.014_bib24","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1158\/1535-7163.1427.3.11","article-title":"Specific inhibition of cyclin-dependent kinase 4\/6 by PD 0332991 and associated antitumor activity in human tumor xenografts","volume":"3","author":"Fry","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ccell.2018.05.014_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1600-0560.1998.tb01748.x","article-title":"p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma","volume":"25","author":"Funk","year":"1998","journal-title":"J.\u00a0Cutan. Pathol."},{"key":"10.1016\/j.ccell.2018.05.014_bib26","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American joint committee on cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ccell.2018.05.014_bib27","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.1158\/0008-5472.CAN-06-0494","article-title":"High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL","volume":"66","author":"Goldstein","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib28","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/jid.2009.5","article-title":"Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors","volume":"129","author":"Haferkamp","year":"2009","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2018.05.014_bib29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10555-005-1582-z","article-title":"Rb\/E2F: a two-edged sword in the melanocytic system","volume":"24","author":"Halaban","year":"2005","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ccell.2018.05.014_bib30","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/sj.onc.1201773","article-title":"Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1(E132), but not by deletion of p16(INK4A) or p21(WAF\/CIP1)","volume":"16","author":"Halaban","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2018.05.014_bib31","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/MCB.16.3.859","article-title":"Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence","volume":"16","author":"Hara","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ccell.2018.05.014_bib32","doi-asserted-by":"crossref","first-page":"11943","DOI":"10.1038\/s41598-017-12165-1","article-title":"High accuracy label-free classification of single-cell kinetic states from holographic cytometry of human melanoma cells","volume":"7","author":"Hejna","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ccell.2018.05.014_bib33","first-page":"5670","article-title":"Characteristics of cultured human melanocytes isolated from different stages of tumor progression","volume":"45","author":"Herlyn","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib34","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1755-148X.2010.00757.x","article-title":"Cancer stem cells versus phenotype-switching in melanoma","volume":"23","author":"Hoek","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib35","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR-Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ng0994-15","article-title":"Germline p16 mutations in familial melanoma","volume":"8","author":"Hussussian","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2018.05.014_bib37","first-page":"528","article-title":"Growth and invasion of human melanomas in human skin grafted to immunodeficient mice","volume":"143","author":"Juhasz","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ccell.2018.05.014_bib38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng0994-22","article-title":"Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus","volume":"8","author":"Kamb","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccell.2018.05.014_bib39","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1747.1998.00211.x","article-title":"Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions","volume":"110","author":"Keller-Melchior","year":"1998","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ccell.2018.05.014_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35092584","article-title":"Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice","volume":"413","author":"Krimpenfort","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.05.014_bib41","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/onc.2012.642","article-title":"Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation","volume":"33","author":"Kumar","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ccell.2018.05.014_bib42","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.9555","article-title":"Survival trends among patients with metastatic melanoma in the United States: a population based study","volume":"35","author":"Kunwor","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ccell.2018.05.014_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ccell.2018.05.014_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jim.2009.09.012","article-title":"Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance","volume":"352","author":"Lin","year":"2010","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ccell.2018.05.014_bib45","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.celrep.2016.04.073","article-title":"Oncogenic BRAF-mediated melanoma cell invasion","volume":"15","author":"Lu","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ccell.2018.05.014_bib46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1158\/2159-8290.CD-15-0196","article-title":"CDKN2B loss promotes progression from benign melanocytic nevus to melanoma","volume":"5","author":"McNeal","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ccell.2018.05.014_bib47","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.05.014_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1098-2744(199705)19:1<17::AID-MC3>3.0.CO;2-K","article-title":"Loss of heterozygosity at loci on chromosome 4, a common genetic event during the spontaneous immortalization of mouse embryonic fibroblasts","volume":"19","author":"Obata","year":"1997","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ccell.2018.05.014_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00008390-200212000-00003","article-title":"Loss of p16 expression is associated with histological features of melanoma invasion","volume":"12","author":"Pavey","year":"2002","journal-title":"Melanoma Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib50","doi-asserted-by":"crossref","first-page":"7969","DOI":"10.1158\/0008-5472.CAN-09-0781","article-title":"Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination","volume":"69","author":"Pinner","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib51","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib52","first-page":"2713","article-title":"Loss of expression of the p16\/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression","volume":"55","author":"Reed","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccell.2018.05.014_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.tibs.2012.10.007","article-title":"Deciphering the retinoblastoma protein phosphorylation code","volume":"38","author":"Rubin","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ccell.2018.05.014_bib54","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1073\/pnas.0912260107","article-title":"Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation","volume":"107","author":"Salomonis","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccell.2018.05.014_bib55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ccell.2018.05.014_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.06.005","article-title":"Genomic and transcriptomic analysis reveals incremental disruption of key signaling pathways during melanoma evolution","author":"Shain","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib57","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","article-title":"The genetic evolution of melanoma from precursor lesions","volume":"373","author":"Shain","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ccell.2018.05.014_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(99)80004-5","article-title":"The INK4A\/ARF locus and its two gene products","volume":"9","author":"Sharpless","year":"1999","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ccell.2018.05.014_bib59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000372-199806000-00006","article-title":"p16 and p21WAF1 protein expression in melanocytic tumors by immunohistochemistry","volume":"20","author":"Sparrow","year":"1998","journal-title":"Am. J. Dermatopathol."},{"key":"10.1016\/j.ccell.2018.05.014_bib60","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jnci\/95.10.723","article-title":"p16\/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: possible implications for melanoma progression","volume":"95","author":"Sviderskaya","year":"2003","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2018.05.014_bib61","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jnci\/94.6.446","article-title":"p16 (Ink4a) in melanocyte senescence and differentiation","volume":"94","author":"Sviderskaya","year":"2002","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ccell.2018.05.014_bib62","first-page":"287","article-title":"Subcellular localization of the retinoblastoma protein","volume":"2","author":"Szekely","year":"1991","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.ccell.2018.05.014_bib63","doi-asserted-by":"crossref","first-page":"e1004873","DOI":"10.1371\/journal.pcbi.1004873","article-title":"CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing","volume":"12","author":"Talevich","year":"2016","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ccell.2018.05.014_bib64","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<255::AID-IJC4>3.0.CO;2-Y","article-title":"Loss of expression of the p16INK4\/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage","volume":"74","author":"Talve","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ccell.2018.05.014_bib65","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nprot.2012.016","article-title":"Differential gene and transcript expression analysis of RNA-seq experiments with tophat and cufflinks","volume":"7","author":"Trapnell","year":"2012","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ccell.2018.05.014_bib66","doi-asserted-by":"crossref","first-page":"55848","DOI":"10.18632\/oncotarget.19862","article-title":"Loss of\u00a0p16(INK4A) stimulates aberrant mitochondrial biogenesis through a CDK4\/Rb-independent pathway","volume":"8","author":"Tyagi","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ccell.2018.05.014_bib67","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm2469","article-title":"Conserved functions of the pRB and E2F families","volume":"9","author":"van den Heuvel","year":"2008","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.ccell.2018.05.014_bib68","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1091\/mbc.e09-12-1029","article-title":"The retinoblastoma protein modulates Tbx2 functional specificity","volume":"21","author":"Vance","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib69","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1996.tb07612.x","article-title":"Immunohistochemical detection of CDK4 and p16INK4 proteins in cutaneous malignant melanoma","volume":"134","author":"Wang","year":"1996","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ccell.2018.05.014_bib70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.stem.2007.10.002","article-title":"Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer","volume":"2","author":"Welm","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.stem.2015.01.003","article-title":"Small molecules enhance CRISPR genome editing in pluripotent stem cells","volume":"16","author":"Yu","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ccell.2018.05.014_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ebiom.2016.04.017","article-title":"Implications of genetic and epigenetic alterations of CDKN2A (p16(INK4a)) in cancer","volume":"8","author":"Zhao","year":"2016","journal-title":"EBioMedicine"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818302289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610818302289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:59:04Z","timestamp":1761523144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610818302289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1535610818302289"],"URL":"https:\/\/doi.org\/10.1016\/j.ccell.2018.05.014","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation","name":"articletitle","label":"Article Title"},{"value":"Cancer Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2018.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2018.06.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.ccell.2018.06.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}